You are here

Meeting Highlights

European Society of Cardiology, 2009 Congress and A Comparison of Two Asthma Medications

Walter Alexander
PDF version: 
At this international cardiology meeting, studies focused on dabigatran (Pradaxa), a promising substitute for warfarin; ticagrelor (Brilinta), a platelet inhibitor; otamixaban, an anticoagulant; and ezetimibe/atorvastatin (Vytorin) for reducing cholesterol levels and other cardiac risk factors. A comparison of beclomethasone-HFA (Qvar) and fluticasone (Flovent) for asthma is also presented.